Skip to main contentSkip to navigation
Sirius Investors
Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

PRDS
NASDAQHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for PRDS. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
98.23M
N/A over period

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
38.95M
N/A over period

Market Cap History

Investor Valuation Insights

As of Jun 30, 2023

EV/EBITDA

Distorted

-0.81x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-59.28M

EV is -60.3% vs equity value

Capital Structure Signal

Net Cash Profile

Trend unavailable for selected history

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 9.31x

Share count trend unavailable

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 202298.23M38.95M$1.6958.13M
Dec 31, 2021931.49M662.82M$16.3756.90M
Dec 31, 20200-3.41M$10.790

Enterprise Value Analysis

Price Change (Dec 2021 to Dec 2022)

The stock price has decreased from Dec 2021 to Dec 2022.
-89.68%

Recent Volatility

The stock price has been relatively stable over the last 2 periods, indicating a lower risk profile.
0.00

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.00

Market Cap Change (Dec 2021 to Dec 2022)

The company's market capitalization has decreased from Dec 2021 to Dec 2022.
-89.45%

Enterprise Value Change (Dec 2021 to Dec 2022)

The company's enterprise value has decreased from Dec 2021 to Dec 2022, suggesting a decline in the company's total economic value.
-94.12%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth